A phase 2 randomized, open-label, parallel group study to assess the immunogenicity, safety, and tolerability of Moderna mRNA-1273 vaccine administered with casirivimab+imdevimab in healthy adult volunteers
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
August 20, 2021
End Date
February 28, 2023
Administered By
Surgery, Surgical Sciences
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
August 20, 2021
End Date
February 28, 2023